Becker’s Healthcare Podcast podcast

Insights on GLP-1 Drugs and Medicare Advantage Trends with Jakob Emerson, Becker’s Healthcare

0:00
14:28
Retroceder 15 segundos
Avanzar 15 segundos

In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, joins Scott Becker to discuss the challenges surrounding GLP-1 drugs in the insurance space and the varied responses to Medicare Advantage headwinds. They explore Elevance Health’s strategies and share insights into how large and small insurers are navigating these issues.

Otros episodios de "Becker’s Healthcare Podcast"